Connecting Drug Delivery128

Issue No #128 Dec 2021 December 10th, 2021

Issue 128 - Dec 2021

Inside the magazine

HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY

HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY

Andreas Alt and Susanne Pianezzi describe the drivers accelerating industry trends towards both wearable subcutaneous injection devices and connecting such devices to monitor patient dosing, providing a number of benefits.

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE

Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.

TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH

TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH

Adam Shain discusses how Aptar is building on the progress made in connected drug delivery devices to help realise their full potential by developing an open, end-to-end platform that will enable healthcare stakeholders to take a holistic view of the full drug delivery journey.

MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS

Miriam Kingsley

MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS

Miriam Kingsley, Marcus Jarman-Smith and Thomas Billings highlight the growing array of applications for high-performance polymers in electronic and connected medical devices and how proper material selection is crucial, providing a guide to successful material selection, going on to showcase its APTIV™ PEEK polymer film, which is well suited to meet the specific demands of next-generation connected medical devices.

eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM

Dr Carola Fuchs

eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM

Carola Fuchs and Simon Buchner describe PARI’s new nebuliser and digital Connect eco-system and how it supports patients, directly and indirectly, through carefully considered device usability in combination with digital therapy management solutions.

Interview: Arnaud Guillet, Biocorp

Interview: Arnaud Guillet, Biocorp

In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.

YPSOMATE ON – GO FOR SIMPLY CONNECTED

Philippe Müller

YPSOMATE ON – GO FOR SIMPLY CONNECTED

Philippe Müller and Silas Mächler discuss the benefits of integrated digital therapy management systems and the role of YpsoMate On – the newest addition to Ypsomed’s connected device portfolio, and the world’s first prefilled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app.

TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS

BD (Becton Dickinson & Company)

TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS

Rebecca Beck and Hervé Monchoix discuss how stakeholder needs are driving the development of a new, connected injection device from BD, to support decentralised and hybrid clinical trials.

USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY

USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY

Brad Moore and Tim Morch describe GCAC’s technology offering, a blockchain-based software system that is able to transparently track the progress of medical cannabis from cultivation through to consumption.

Top